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PENILAIAN PARAS KORTISOL, RANKL DAN OPG AIR LIUR DALAM 
PESAKIT PERIODONTITIS KRONIK DI HOSPITAL UNIVERSITI SAINS 
MALAYSIA 
ABSTRAK 
Periodontitis kronik (CP) adalah jangkitan inflamasi gred rendah yang berlaku 
pada struktur periodontal yang disebabkan oleh kehadiran flora patogenik dan plak 
biofilem yang berinteraksi dengan sistem imun dalam tempoh tertentu. Tabiat merokok, 
pengambilan alkohol, tekanan, kegemukan, sindrom metabolik, diabetes melitus, 
keadaan-keadaan serta penyakit-penyakit sistemik yang lain telah dikenal pasti sebagai 
faktor berisiko terhadap penyakit ini. Tujuan kajian ini adalah untuk mengkaji dan 
menilai perkaitan di antara paras kortisol serta biopenanda protein RANKL dan OPG 
dalam air liur pesakit CP. Dalam kajian keratan rentas ini, data sosio-demografik, 
parameter periodontal klinikal [kedalaman poket periodontal (PPD), aras atakmen 
klinikal (CAL), skor plak (PS) dan indeks pendarahan gingiva (GBI)] telah diambil dan 
skor DASS-21 telah dinilai berdasarkan borang soal selidik. Kepekatan kortisol serta 
protein RANKL dan OPG dalam air liur telah dinilai dalam kumpulan pesakit yang 
terdiri daripada subjek yang sihat iaitu kumpulan 1, pesakit CP tahap ringan iaitu 
kumpulan 2 serta pesakit CP tahap sederhana hingga teruk iaitu kumpulan 3 di Klinik 
Periodontik, Pusat Pengajian Sains Pergigian, Hospital Universiti Sains Malaysia. Min 
kortisol, protein RANKL dan OPG dalam air liur adalah tinggi dalam kumpulan 3 
(pesakit CP tahap sederhana hingga teruk) iaitu sebanyak 7.46 ng/ml, 0.23 ng/ml, dan 
1.78 ng/ml, mengikut turutan. Keputusan soal selidik DASS-21 menunjukkan kumpulan 
xvi 
 
3 mempunyai skor yang lebih tinggi terhadap kemurungan, kebimbangan dan tekanan. 
Skor DASS-21 juga menunjukkan perkaitan secara signifikan di antara paras kortisol air 
liur dengan kedua-dua kumpulan pesakit CP iaitu tahap ringan (kumpulan 2) serta tahap 
sederhana hingga teruk (kumpulan 3). Kesimpulannya, tekanan yang tinggi berpotensi 
menjadi faktor berisiko yang berkait dengan peningkatan kelesapan tulang bagi pesakit 
CP di Kelantan. Penurunan paras protein OPG dan peningkatan paras protein RANKL 















EVALUATION OF SALIVARY CORTISOL, RANKL AND OPG LEVELS IN 
CHRONIC PERIODONTITIS PATIENTS ATTENDING HOSPITAL 
UNIVERSITI SAINS MALAYSIA 
ABSTRACT 
Chronic periodontitis is a low grade inflammatory infection of supporting 
periodontal structure ocurring in the presence of pathogenic flora and plaque biofilm 
interaction with immune system over a period of time. Multiple risk factors such as 
smoking, alcohol intake, stress, obesity and metabolic syndrome, diabetes mellitus, other 
systemic diseases or conditions have been identified as a potential risk factors for this 
disease. The aim for this study is to assess and evaluate the association between levels of 
salivary cortisol, RANKL and OPG protein biomarkers in chronic periodontitis (CP) 
patients. In this cross sectional study, clinical periodontal parameters [periodontal pocket 
depth (PPD), clinical attachment level (CAL), plaque score (PS) and gingival bleeding 
index (GBI)] were performed and DASS-21 scores were assessed from the survey form. 
Protein concentrations for salivary cortisol, RANKL and OPG were assessed in study 
groups consisting of mild chronic periodontitis patients in group 2, moderate to severe 
chronic periodontitis patients in group 3 and healthy subjects in group 1 at Periodontic 
Clinics of  School of Dental Sciences, Hospital Universiti Sains Malaysia. Mean levels 
for salivary cortisol, RANKL and OPG protein were higher for group 3 (moderate to 
severe chronic periodontitis) with 7.46 ng/ml, 0.23 ng/ml and 1.78 ng/ml. Higher 
depression, anxiety and stress score were  also noted for group 3 (moderate to severe 
chronic periodontitis) from DASS-21 questionairre. DASS scores were significantly 
xviii 
 
associated with salivary cortisol levels in both mild and moderate to severe chronic 
periodontitis groups. In conclusion, high stress is considered as a potential risk factor 
associated with increase bone loss in chronic periodontitis in Kelantanese population. 
Low OPG and high RANKL protein levels are responsible for higher bone loss in mild 





CHAPTER 1.  
             INTRODUCTION 
 
1.1 Background of the study 
The oral cavity is a unique diverse environment which harbors an immense number of 
microscopic organisms of various species within the soft  tissues like oral mucosa and 
hard tissues of the teeth. Oral environment consists of aerobic and anaerobic 
microorganisms that favours the temperate and gentle environment of oral cavity 
forming a multiplex structure and a stable biological community (Marsh and Martin, 
1992). However, often these microbes can cause periodontal diseases like chronic 
periodontitis and gingivitis, which are seen to be the most commonly detected microbial 
diseases affecting the humans across the globe (Albandar 2002). 
           The bacterial species especially the red-complex are actively linked with 
periodontal disease, which include the bacteria Porphyromonas gingivalis, Tannerella 
forsythia and Treponema denticola. Other than the red complex, Aggregatibacter 
actinomycetemcomitans and Eubacterium nodatum are notably associated with 
periodontal disease (Darveau, 2010). The gram-negative microorganisms were 
considered as the etiologic determinants of the periodontal diseases and affected the 
clinical parameters which led to periodontitis (Darveau 2010; Yang et al., 2016). 
Initiation and advancement of periodontitis occur as a combination of genetic and 
ecological variables including negligence of oral hygiene, stress/anxiety/depression, 
smoking and systemic diseases (Dibart, 2009).  
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Many studies have noted that if proper cleaning and brushing of teeth were 
neglected, the oral bacteria form a microbial film on the teeth surfaces. This microbial 
film includes many enzymes, proteins and cellular debris, which is present in the saliva, 
in addition to the food particles that enter the mouth. All these factors are responsible for 
the formation of a plaque biofilm on the surface of the teeth. This plaque film leads to a 
further bacterial invasion in the deeper periodontal structures, like the collagen layers. 
This triggers the breakdown of the periodontal structure due to the microbial attack and 
the corresponding host responses (Hajishengallis, 2014). The different external or 
internal stimuli activate the host immune-inflammatory response, which is the main 
mechanism that maintains the oral periodontal health. The inflammatory response 
triggers many macrophages, neutrophils, cytokines, and activates the T- and B-
lymphocytes and finally, the complement system (Abbas et al., 2014). Cytokines are 
produced and secreted by immune and non-immune cells in our body. Cytokines are 
able to initiate  and control a channel of events that cause the up or down regulation of 
specific genes. Hence, these cytokines are responsible for modifying pro-inflammatory 
and anti-inflammatory response occuring within the body (Garlet, 2010; Graves, 2008).  
A persistent and chronic inflammatory reaction activates some inflammatory 
molecules like matrixmetalloproteinases (MMPs) and the receptor activator of nuclear 
factor-κB (RANKL) ligand (Lacey et al., 1998; Sorsa et al., 2004). Two pre-
inflammatory cytokine molecules like the Tumour Necrosis Factor-alpha (TNF-α) and 
Intereukin-1 beta (IL-1β) increase the RANKL secretion via the T and B cells (Van 
Dyke 2007; Chen et al., 2014). However, OPG was a soluble antagonist receptor that 
inhibited the osteoclast differentiation as it competed with the RANKL for the receptor 
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(Simonet et al., 1997). The ratio of the RANKL and OPG molecules is a good indicator 
of the bone tissue degradation during the progression and severity of the periodontal 
diseases (Belibasakis and Bostanci 2012). 
Stress is the protective response of the body against any internal or external 
factor that can harm the body, i.e., stressors. McEwen (2000) stated that any event or 
scenario which is regarded as scary or frightening to the person can trigger the 
behavioural and physiological responses in the person. During this process, the central 
nervous system gets activated via the Hypothalamus Pituitary Adrenal Axis (HPAA) 
activity, which triggers the hypothalamus to activate and secrete Corticotropin-Releasing 
Hormone (CRH). The adrenal cortex is also triggered to release glucocorticoids like 
cortisol (Chrousos 1995). These molecules increase the stress levels in the individual. 
Glucocorticoids downregulate the immunological expression by activating the 
leukocyte molecules and inhibiting the growth of cytokine molecules like the Intereukin 
1-beta (IL-1b), IL-6 and other inflammatory mediators (Chrousos 1995). The 
physiological events which are further activated due to the HPAA mechanism also 
decrease the immunity of the body since they suppress the activities of the IgA, IgG and 
neutrophils. All these factors increase the probability of a severe infection, which is 
responsible for causing destructive periodontitis (Wein 2000; Khayat 2007). 
Psychosocial stress triggers many autonomic nervous system-based reactions, which 
cause a catecholamine secretion (i.e., epinephrine and norepinephrine) that affects the 
prostaglandins and increases the activity of the proteases. This complete chain of events 
significantly aggravates the periodontal breakdown and damage (Dimsdale and Moss 
1980). The health of the periodontal tissue is affected by the daily stresses, which affect 
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the lifestyle of the person in many ways. Some of the other factors which affect 
periodontal health include alcohol consumption, smoking, neglecting oral hygiene and 
improper dental care (Jaiswal et al., 2016). 
Many researchers have considered the salivary cortisol levels as an important 
stress biomarker in their studies. The cortisol hormone is a glucocorticoid, which is 
synthesised and released by the adrenal cortex. It is present and detected in all the body 
fluids, like the gingival crevicular fluid (GCF), serum, urine, saliva, and blood (Genco et 
al., 1998; Mengel et al., 2002). This hormone shows many immunosuppressive and anti-
inflammatory functions and properties, which prevent the lymphocyte formation and 
induces lymphatic tissue hyperplasia (Snell 1976). This further decreases the humoral 
immune defence of the body. Cortisol is a common stress biomarker, and the salivary 
cortisol levels are measured for assessing many systemic and psychological diseases 
(Hjortskov et al., 2004). Cortisol is seen to inhibit the proliferation of the fibroblasts in 
the inflammatory granulation tissue, which affects the homeostasis of the immune 
system  (Hagan et al., 1992).  
Saliva is a very important body fluid which displays many advantages. It 
possesses many properties that assist in diagnosing the different oral conditions and 
diseases like oral cancer, periodontitis, Alzheimer’s disease, etc. (Nagler 2009). 
Furthermore, it shows many advantages, like it is easily available, inexpensive, can be 
collected and stored without any hassle (Dolan et al., 2004). Also, a saliva sample can be 
collected at any time of the day, without any specific clinical setting. Unlike the other 
body fluids like the serum, blood, CSF, etc., saliva collection does not require an 
invasive or difficult process (Pfaffe et al., 2011). Saliva contains many proteins and 
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biomarkers that can offer an important link to the different diseases and conditions 
affecting the human body. These biomarkers are still under investigation (Al Kawas et 
al., 2012). 
In this study, the researchers have investigated the salivary cortisol levels as the stress 
biomarker. Additionally, they circulated a Malay-translated version of the DASS-21 
questionnaire for determining the stress levels of the people included in the study 
groups. This Malay-translated, DASS 21 questionnaire was a shorter version of the 
original DASS 42 questionnaire that was developed by Lovibond (1995). It shows 
internal consistency and reliability and can be used for determining the stress-related 
symptoms. However, it was not used for the clinical diagnosis of psychological 
disorders (Musa et al., 2007; Tran et al., 2013; Wang et al., 2016). 
There are very few studies which have determined the stress levels and its subsequent 
effect on oral health in the Malaysian population. This is the first study which has 
analysed the mean concentration of the salivary cortisol hormone, OPG, RANKL, along 
with anxiety, stress and depression levels in the respondents who suffered from mild or 
severe periodontitis. These levels were correlated to the periodontal parameters noted for 
every group. 
1.2   Problem statement & justification of the study 
In view of periodontal disease initiation and progression, the role of protein 
biomarkers such as RANKL and OPG in inflammatory process could be correlated with 
the stress condition among chronic periodontitis patients. The studies investigating such 
relationship are scarcely reported. Thus, present study will be looking on the salivary 
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cortisol and protein biomarkers RANKL and OPG levels. Stress scores using DASS-21 
questionairre between healthy subjects, mild and moderate to severe chronic 
periodontitis patients will be assessed in this study. Association among all these 
variables with periodontal clinical parameters will be assessed. Additionally, correlation 
among all these variables with periodontitis disease severity and progression was also 
evaluated in this study. 
The earlier studies noted a positive correlation between the serum and salivary 
cortisol levels and the initiation and progression of the periodontal disease. However, 
these studies did not indicate a clear cause and effect relationship between the stressors, 
salivary cortisol levels and the periodontitis disease. Hence, the actual mechanism which 
involves the salivary cortisol levels and the periodontal disease is still unknown (Rai et 
al., 2011). Stress was seen to be a potential risk factor which led to the onset of the 
periodontal disease as it could affect the local oral hygiene of the individual. This 
affected the release of the cortisol hormone from the HPPA centre into the blood or 










1.3   Objectives of the study 
1.3.1  General objective 
To evaluate the association among levels of salivary cortisol, RANKL and OPG 
protein biomarkers in chronic periodontitis (CP) patients. 
1.3.2  Specific objectives 
i. To assess and compare the levels of salivary cortisol, protein biomarkers RANKL 
and OPG  and periodontal parameters among healthy subjects with mild and 
moderate to severe chronic periodontitis patients 
ii. To assess and compare the stress (DASS-21 scores) among healthy subjects with 
mild and moderate to severe chronic periodontitis patients. 
iii. To assess the association of the salivary cortisol level, protein biomarkers (RANKL 
and OPG), RANKL/OPG ratio and stress (DASS-21) with periodontal parameters in 
chronic periodontitis patients. 
1.3.3  Research questions 
1. Is there any difference between the levels of salivary cortisol, protein biomarkers 
RANKL and OPG among healthy group, mild and moderate to severe chronic 
periodontitis patient groups? 
2. Is there any difference between the scores of DASS-21 among healthy group, 
mild and moderate to severe chronic periodontitis patient groups? 
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3. Are there any association in the levels of salivary cortisol, protein biomarkers 
RANKL and OPG, RANKL/OPG ratio to the periodontal clinical parameters 
and stress in chronic periodontitis patients? 
1.3.4  Research hypothesis 
i) There is a significant difference in the levels of salivary cortisol, protein biomarkers 
(RANK and OPG) levels with increase periodontal parameters between the healthy 
subjects, mild periodontitis and moderate to severe chronic periodontitis patients. 
ii) There is a significant association of salivary cortisol levels, protein biomarkers (OPG 
and RANKL) and stress levels in healthy subjects, mild periodontitis and moderate 
to severe chronic periodontitis patients. 
iii) There is a significant difference in the DASS-21 score between healthy subjects, 




CHAPTER 2.  
LITERATURE REVIEW 
2.1 Periodontium 
Periodontium is the fundamental part of the tooth which consists of four major 
components named gingiva, cementum, periodontal ligament and alveolar bone (Reddy, 
2017) as shown in the Figure 2.1 adapted from Xu and coworkers (Xu et al., 2018).  
Healthy periodontium is superficially covered with the resilient layer of gingiva, 
forming a barrier against mechanical and microbial damages. Histologically, gingiva 
comprises of gingival epithelium and the gingival connective tissue (Bashir et al., 2018). 
A shallow crevice between gingival epithelial lining and tooth is known as gingival 
sulcus. Clinically this space is measured using a periodontal probe (a metalic 
instrument). In clinically healthy gingiva, this probing depth is up to 3 mm. Probing is 
one of the most significant clinical parameters used to assess the periodontal status 
(Lang and Bartold, 2018). 
Beneath the gingiva, teeth are anatomically positioned within the alveolar bone 
(Listgarten et al., 1991). The periodontal ligament fibers (PDL) are the connective 
tissues produced by the fibroblasts, they stretch across the space between the alveolar 
bone and root surface (de Jong et al., 2017). Cementum is the hard tissue covering the 
root surface. It aids in anchoring the tooth through insertion of Sharpey’s fiber and 
providing support to periodontal ligament fibers. It also helps in protecting the pulp 





Figure 2.1  Schematic drawing of healthy and diseased periodontium (Figure adapted 
from Xu et al.,2018). 
 
2.2   Periodontal disease 
Periodontal diseases are microorganism induced inflammatory chronic condition 
that affect the teeth supporting structure. This polymicrobial infectious disease starts 
with establishment and growth of a small group of gram-negative anaerobic bacteria 
mainly consisting of P. gingivalis, Aggregatibacter actinomycetemcomitans, P. 
intermedia, spirochetes and others (Mira et al., 2017). These bacteria along with 
thousands of other bacterial species within the plaque biofilms, made their way apically 




slowly cause the degradation of the alveolar bone and collagenous fibers of the 
periodontal ligament (Page et al., 1997).  
Bacterial biofilm forms on the teeth surface shelter and provides a chronic 
microbial stimulus which initiates a local inflammatory response within the gingival 
mesh (Pihlstrom et al., 2005). Although bacteria are mandatory for periodontal disease 
to initiate but they also require various factors or determinants such as multiple host and 
environmental aspects for example genetic predisposition, lifestyle, oral hygiene 
measures, systemic conditions and diseases and psychological stress contribute towards 
onset and progression of periodontitis (Genco and Borgnakke, 2013). 
Periodontal disease stability is defined as a state in which the periodontitis has 
been successfully treated through control of local and systemic factors, resulting in 
minimal bleeding on probing (BoP), optimal improvements in periodontal pocket depth 
(PPD) and clinical attachment levels (CAL), and a lack of progressive destruction.  
Clinical signs of the disease do not appear to worsen in extent or severity despite the 
presence of a reduced periodontium (Lang and Bartold, 2018; McKay, 2019). 
Periodontal disease remission/control is defined as a period during disease when 
symptoms become less severe, but the diseases is not in its active state or condition. This 
may be a reasonable treatment outcome for individuals with uncontrollable modifying 
factors. Indeed, for many chronic inflammatory medical conditions such as diabetes 
mellitus, cardiovascular disease, hyperlipidemia, and rheumatoid arthritis, the goal of 
disease remission is important and is based on the emerging concept of treat to target 




The non-surgical periodontal therapy is to halt the progression and control the 
factors contributing in the periodontal inflammation by the mechanical and chemical 
debridement of subgingival bacterial deposits and the subsequent control of plaque 
levels by patients (Greenstein, 1992). Non-surgical therapy consists of several basic 
clinical procedures including scaling, root planing, oral hygiene instruction, proper 
counselling as well as other therapies such as caries control, replacement of defective 
restorations, occlusal therapy, orthodontic movement, and smoking cessation (Pihlstrom 
et al., 1981). 
 
2.3   Periodontitis 
Periodontitis is the inflammatory condition of the periodontium induced by 
bacteria. As the disease progresses, it causes degenerative changes in the periodontium, 
resulting in the loss of periodontal ligament and alveolar bone. Subsequently, the 
gingival sulcus deepens and forms periodontal pocket (Kurgan and Kantarci, 2018).  
A patient is defined as periodontitis case as reported in the concensus report 2017 
(Papapanou et al., 2018). 
1. Interdental CAL is detectable at ≥2 nonadjacent teeth, or 
2. Buccal CAL ≥3 mm with pocketing ≥3 mm is detectable at ≥2 teeth but the observed 
CAL cannot be ascribed to non-periodontitis related causes such as: gingival recession 
of traumatic origin; dental caries extending in the cervical area of the tooth; the presence 




extraction of a third molar, an endodontic lesion draining through the marginal 
periodontium; and the occurrence of a vertical root fracture. 
It is proposed that there are 4 levels of periodontal health, depending on the state 
of the periodontium (structurally and clinically sound or reduced) and the relative 
treatment outcomes:  
(1) pristine periodontal health, with a structurally sound and uninflamed periodontium;  
(2) well‐ maintained clinical periodontal health, with a structurally and clinically sound 
(intact) periodontium;  
(3) periodontal disease stability, with a reduced periodontium, and  
(4) periodontal disease remission/control, with a reduced periodontium. 
2.3.1 Classification of periodontitis 
Classification of any disease is of great significance, when it comes to diagnose 
down the disease along with provision of better treatment regimen. Multiple 
classification schemes had been proposed, adopted and acknowledged in the past, of 
which the most renowned was from the Armitage (Armitage, 1999) classification for 
periodontal disease and conditions in 1999. However, recently in 2017, a world 
workshop was organized in which consensus was made after reviewing, debating and 
mutually agreeing on the overall conclusions made by the committee members and 




1. In this new periodontitis classification scheme forms of the disease previously 
recognized as “chronic” or “aggressive” are now grouped under a single category 
“periodontitis” and are further characterized based on a multi‐ dimensional staging 
and grading system.  
2. Staging is largely dependent upon the severity of disease at presentation as well as 
on the complexity of disease management, while grading provides supplemental 
information about biological features of the disease including a history‐ based 
analysis of the rate of periodontitis progression; assessment of the risk for further 
progression; analysis of possible poor outcomes of treatment; and assessment of the 
risk that the disease or its treatment may negatively affect the general health of the 
patient. 
2.3.2  Prevalence of periodontitis 
 According to the reports 13-35% of adult population residing in industrialized 
countries are suffering from periodontitis disease and approximately 5-8% of them 
suffer from aggressive periodontitis disease (Johannsen, 2006; Milosavljevic, 2018). The 
prevalence of severe chronic periodontitis (CP) varies worldwide from 10% to 15% in 
adult population according to World Health Organisation (WHO) (Petersen and Ogawa, 
2012). The latest epidemiological data in the USA has corroborated the high prevalence 
of periodontitis disease in more than 47% of adult population (Eke et al., 2012b).  
In the National Oral Health Survey of Adults undertaken by the Oral Health 




Approximately, 90% of the population aged between 45 and 70 apparently had 
periodontal problems (Chan et al., 2012). Extreme cases of periodontal disease severity 
with more pocket depths and cinical attachment loss were reported in Songkhla, which is 
a province of Southern Thailand. It was predicted that these individuals showed more 
severity of periodontal diseases when compared to the rest of Asian populations (Corbet 
et al., 2002). A higher rate of periodontal disease was also found out in Taiwan, 
according to one of the community-based studies in Keelung (Lai et al., 2007).  
Another cross-sectional periodontal study was carried out in Vietnam, targeting 
middle aged group people from two different provinces in which periodontal disease 
status was measured clinically showed a significant periodontal attachment loss (Do et 
al., 2003). In Japan a national level study was conducted and demonstrated that 42% of 
the tooth loss was due to periodontal diseases and conditions (Aida et al., 2006). 
2.3.3  Aetiology of periodontitis 
The aetiology and pathogenesis for gingivitis and periodontitis disease has been 
studied vastly in the past. With the emerging modern technology more advance genetic 
and molecular studies have been carried out on this disease which revealed the complex 
microcellular pathways through which periodontal disease initiates and progresses 
(Bostanci and Bao, 2017; Dentino et al., 2013). The comprehension of periodontal 
disease in early 1950’s was that when left untreated disease pursued an advancement 
from gingivitis to periodontitis leading ultimately to tooth loss (Arnold et al., 1966; 
Lang et al., 2009; Moosani, 2012; Schätzle et al., 2009; Teles et al., 2013). Later, in the 




etiology of the periodontal disease (Jordan and Keyes, 1964; Kahnberg et al., 1976; 
Socransky and Haffajee, 1992). This concept was elaborated and practiced by some of 
the longitudinal studies carried out during 80’s to 90’s decades. These longitudinal 
studies proposed that it is not only the bacterial plaque microorganism interaction which 
initiates the periodontal disease but the underlying host immune reaction within the body 
also contributes towards disease initiation and progression (Dentino et al., 2013; 
Kulkarni and Kinane, 2014).  
Although this dental plaque or biofilm is considered as a primary requisite to 
promote the local infection or disease. It also depends upon the host’s inflammatory-
immune responses to occur in the presence of the microbial overload which in turn 
causes the initiation, progression and destruction of the periodontium (Darveau, 2010; Li 
et al., 2017). A local inflammatory reaction activating the innate immune system of the 
body takes place in the very first stage in response to the underlying bacterial infection 
(Graves and Cochran, 2003). Recent studies concluded that periodontitis pathogenesis 
occurs as a result of overload and shifting of multiple bacterial species from healthy to 
diseased state under the influence of immune-inflammatory reactions which causes the 
bone loss and degradation of periodontal structures (Abusleme et al., 2013; 
Hajishengallis et al., 2012). 
2.3.4  Pathogenesis of periodontitis 
Periodontitis is seen as a long-term plaque persistence at the dento-gingival 
interface resulting in an advancement and maturation of the dental biofilm, along with 




of the supporting tooth structures (Lalla and Papapanou, 2011). Subgingival habitat 
under the normal conditions contains a balanced homeostatic relation between innate 
and immune inflammatory mediators and microbial niche (Hajishengallis, 2015; Meyle 
and Chapple, 2015).  
A pathogenic biofilm is considered as a primary prerequisite for the periodontal 
inflammation to start and initiate in the first place (Johansson and Dahlén, 2018) 
however, this dental biofilm on its own cannot initiate any inflammatory reaction or 
process because the whole procession requires an interaction of host response, 
inflammatory immune responses within the body (Kurgan and Kantarci, 2018). 
Initial host immune inflammatory reaction mediates neutrophils, which fails to 
maintain this homeostatic balanced environment, paving path for the penetration and 
intrusion of pathogenic microorganisms within the connective tissues and there they 
interact with various other types of immune cells like macrophages, dendritic cells, T 
cell types and a subset of innate like cells. These cells further produce proinflammatory 
mediators like bone degrading cytokines like interleukin 1-beta (IL-1b), interleukin 17 
(IL-17), tumour necrosis factor (TNF) subclass enhancing destructive process. 
Moreover, Th helper (Th) cells production and regulation during this process is under 
the control of these pro inflammatory mediators, which are highly responsible for 
escalating inflammatory response (Hajishengallis, 2014).  
More recently a number of independent multi genomic and programmatic oral 
microbial studies revealed a polymicrobial synergy and dysbiosis (PSD) model. This 




microflora. Numerous species of microorganisms take part in the pathogenesis of 
periodontitis, which are considered to play an important role during disease course 
(Hajishengallis, 2014; Hajishengallis and Lamont, 2012; Lasserre et al., 2018). 
According to this PSD model, Porphyromonas gingivalis is the main pathogen 
responsible for disruption of periodontal homeostasis as well as it compels and obligates 
the surrounding flora, pathogens called as pathobionts consisting of various microbial 
colonies to stampede and results in the inflammatory tissue disruption (Zenobia and 







Figure 2.2  A schematic diagram showing keystone pathogens influencing the 
periodontal inflammation. (Figure adapted from Hajishengallis and Lamont 2014) 
 
 
2.3.5  Bone Metabolism 
Bone is the specialized connective tissue comprising of various cells, 
collagenous and inorganic matrix (Green and Kleeman, 1991). Alveolar bone resorption 
is the result of excessive osteoclastic activity that leads to an imbalance in bone 
remodeling (Mundy, 1993). The level of bone mass which is essential to execute various 
functions is maintained by a balanced act of bone formation and bone resorption 
(Hadjidakis and Androulakis, 2006). This process is highly coordinated and regulated by 




resorbing cells (Rodan, 1992). These cells are controlled by various hormones, 
inflammatory mediators, cytokines and growth factors (Lu et al., 2006; Lumachi et al., 
2009). Remodeling of alveolar bone occurs in different environments. Physiologically, it 
occurs during tooth eruption as well as during normal occlusal forces (Saffar et al., 
1997). It also occurs as a result of clinical interventions such as orthodontic tooth 
movements. Pathological conditions that cause bone resorption include periodontal 
disease, periapical pathologies, granulomas and tumors (Lerner, 2004). 
2.3.6  Osteoclastogenesis occurring at cellular level in periodontitis 
Osteoclasts are large multinucleated cells characterized by their ability to resorb 
bone (Feng and Teitelbaum, 2013). They are derived from hematopoietic stem cells 
within the bone marrow and their mononuclear precursors are typically found circulating 
in peripheral blood (Väänänen, 2005). Osteoclasts are differentiated through two 
regulatory cells including RANKL and macrophage colony stimulating factor (M-CSF) 
(Boyle et al., 2003). 
The great amount and interactions of bacterial end products with various 
inflammatory stimuli primarily lipopolysaccharide with the periodontal and immune 
cells stimulates the differentiation of osteoclasts and thus activates pathologic bone loss. 
These factors influence the state and progression of the periodontal disease (Garlet, 
2010). Several biomolecules are produced during periodontal inflammation, these 
biomolecules are also known as biomarkers (Ebersole et al., 2015). These biomarkers 
lead towards connective tissue invasion and breakdown of alveolar bone. Levels of these 




patients (Frodge et al., 2008). RANKL and OPG are two important biomarkers that 
plays a significant role in periodontal bone loss process. 
Various inflammatory cytokines including IL-1, IL-6, IL-17, TNF-a, PGE-2, 
MMP’s are involved in the pathogenesis of periodontitis. However, the key cytokine 
system that regulates bone remodeling process is dependent on the receptor activator of 
nuclear factor-kappa B ligand (RANKL) and Osteoprotegerin (OPG) balance (Hofbauer 
et al., 2001). RANKL causes the maturation of osteoclast precursors (OCPs) leading to 
bone resorption in periodontitis (Hajishengallis, 2014). This mechanism is shown in the 
figure 2.3. 
Infiltrated leukocytes produce IL-1 & prostaglandins E2 (PGE2) through 
osteoblasts, periodontal fibroblast & gingival fibroblasts (Lu et al., 2006). PGE2 is 
produced by immune cells, fibroblasts and other resident gingival cells and has a wide 
range of biological effects on the cells of the diseased gingiva (Zhang et al., 2010). 
PGE2 include the stimulation of MMPs and causes osteoclast formation via receptor 
activator of nuclear factor-κB ligand (RANKL) (Bage et al., 2011; Hienz et al., 2015b). 
Interleukin-17 (IL-17) is also thought to contribute in the bone resorption process in 
periodontitis. IL-17 mediates the production of matrix metalloproteinases (MMPs), 
chemokines along with other mediators of bone metabolism (TGF-β, PTH, 1,25-
dihydroxyvitamin D3, glucocorticoids and estrogen) and tissue-destructive molecules 





TNFα and IL-1 are synthesised by many cell types in the periodontal tissue such 
as monocytes/ macrophages, PMN cells, fibroblasts, epithelial cells, endothelial cells 
and osteoblasts (Cekici et al., 2014; Kayal, 2013). TNFα is released from mast cells in 
response to bacterial challenge and triggers the bone loss process in periodontitis 
(Yucel-Lindberg and Bage, 2013). In clinical context, TNFα and IL-1β have been found 
in increased concentrations in GCF and gingival tissue of periodontitis sites (Hernandez 
et al., 2011). At the cellular level, these two cytokines can induce and trigger several 
other mediators including IL-6, IL-8, matrix metalloproteinases (MMPs) and PGE2 





Figure 2.3  A schematic diagram showing the inflammatory mechanisms leading to bone 
loss in periodontitis (Figure adapted from Hajishengallis, 2014). 
 
 
Thus, if the molecular mechanism of alveolar bone were elucidated in detail, 
prognosis of the periodontal lesion will be more accurately diagnosed & appropriate 




controlling bone resorption, imbalances in its expression may cause a switch from a 
physiological to a pathological bone loss in different sites. 
2.3.7 Physiological role of RANK, RANKL and OPG system 
RANKL acts by connecting to RANK on the surface of preosteoclast/ osteoblast 
cells, resulting in the enhancement of osteoclasts activity (Cochran, 2008; Martin and 
Ng, 1994). Through this activation, it triggers the fusion and differentiation of pro 
osteoclasts into mature osteoclasts, thus activating bone resorption (Kostenuik, 2001; 
Quax et al., 2018; Theoleyre et al., 2004; Xiao et al., 2016). At times this action is 
blocked by the homologous decoy receptor known as osteoprotegerin (OPG), which is 
also a member from TNF superfamily (Locksley et al., 2001; Sojod et al., 2017). OPG 
attaches itself onto the surface of RANK, causing deregulation of molecular and cellular 
events taking place in osteoclastic process (Cavalla et al., 2018; Theoleyre et al., 2004). 
Below mentioned figure 2.4 is showing the schematic illustration and representation of 
RANKL-RANK-OPG system (Khosla, 2001). In this figure RANK-RANKL and OPG 
system and its brief process has been summarized. RANKL expressed on the surface of 
preosteoblastic/stromal cells, binds to RANK on the osteoclastic precursor cells. 
Macrophage-colony stimulating factor (M-CSF), which binds to its receptor, colony 
stimulating factor gene encoded CSF1R (c-Fms), on to the preosteoclastic cells, appears 
to be necessary for osteoclast development because it is the primary determinant of the 
pool of these precursor cells (Udagawa et al., 1990). A number of proresorptive 
cytokines, such as TNF-α and IL-1, modulate this system primarily by stimulating M-
